 |
|
Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Nila J. Dharan, MD;
Larisa V. Gubareva, PhD;
John J. Meyer, MPH;
Margaret Okomo-Adhiambo, PhD;
Reginald C. McClinton, MPH;
Steven A. Marshall, MS;
Kirsten St. George, MAppSc, PhD;
Scott Epperson, MPH;
Lynnette Brammer, MPH;
Alexander I. Klimov, PhD;
Joseph S. Bresee, MD;
Alicia M. Fry, MD, MPH; for the Oseltamivir-Resistance Working Group
JAMA. 2009;301(10):1034-1041. Published online March 2, 2009 (doi:10.1001/jama.2009.294).
Context During the 2007-2008 influenza season, oseltamivir resistance among influenza A(H1N1) viruses increased significantly for the first time worldwide. Early surveillance data suggest that the prevalence of oseltamivir resistance among A(H1N1) viruses will most likely be higher during the 2008-2009 season.
Objectives To describe patients infected with oseltamivir-resistant influenza A(H1N1) virus and to determine whether there were any differences between these patients and patients infected with oseltamivir-susceptible A(H1N1) virus in demographic or epidemiological characteristics, clinical symptoms, severity of illness, or clinical outcomes.
Design, Setting, and Patients Influenza A(H1N1) viruses that were identified and submitted to the Centers for Disease Control and Prevention by US public health laboratories between September 30, 2007, and May 17, 2008, and between September 28, 2008, and February 19, 2009, were tested as part of ongoing surveillance. Oseltamivir resistance was determined by neuraminidase inhibition assay and pyrosequencing analysis. Information was collected using a standardized case form from patients with oseltamivir-resistant A(H1N1) infections and a comparison group of patients with oseltamivir-susceptible A(H1N1) infections during 2007-2008.
Main Outcome Measures Demographic and epidemiological information as well as clinical information, including symptoms, severity of illness, and clinical outcomes.
Results During the 2007-2008 season, influenza A(H1N1) accounted for an estimated 19% of circulating influenza viruses in the United States. Among 1155 influenza A(H1N1) viruses tested from 45 states, 142 (12.3%) from 24 states were resistant to oseltamivir. Data were available for 99 oseltamivir-resistant cases and 182 oseltamivir-susceptible cases from this period. Among resistant cases, median age was 19 years (range, 1 month to 62 years), 5 patients (5%) were hospitalized, and 4 patients (4%) died. None reported oseltamivir exposure before influenza diagnostic sample collection. No significant differences were found between cases of oseltamivir-resistant and oseltamivir-susceptible influenza in demographic characteristics, underlying medical illness, or clinical symptoms. Preliminary data from the 2008-2009 influenza season identified resistance to oseltamivir among 264 of 268 influenza A(H1N1) viruses (98.5%) tested.
Conclusions Oseltamivir-resistant A(H1N1) viruses circulated widely in the United States during the 2007-2008 influenza season, appeared to be unrelated to oseltamivir use, and appeared to cause illness similar to oseltamivir-susceptible A(H1N1) viruses. Circulation of oseltamivir-resistant A(H1N1) viruses will continue, with a higher prevalence of resistance, during the 2008-2009 season.
Author Affiliations: Epidemic Intelligence Service, Office of Workforce and Career Development Assigned to Influenza Division (Dr Dharan), and Influenza Division (Drs Gubareva, Okomo-Adhiambo, Klimov, Bresee, and Fry and Ms Brammer and Mr Epperson), Centers for Disease Control and Prevention, Atlanta, Georgia; Arizona Department of Health Services, Phoenix (Mr Meyer); Wyoming Department of Health, Cheyenne (Mr McClinton); Wisconsin State Laboratory of Hygiene, Madison (Mr Marshall); and Wadsworth Center, New York State Department of Health, Albany (Dr St. George).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Morbidity and Mortality Associated With Nosocomial Transmission of Oseltamivir- Resistant Influenza A(H1N1) Virus
Jairo Gooskens, Marcel Jonges, Eric C. J. Claas, Adam Meijer, Peterhans J. van den Broek, and Aloys C. M. Kroes
JAMA. 2009;301(10):1042-1046.
ABSTRACT
| FULL TEXT
The Evolution of Influenza Resistance and Treatment
David M. Weinstock and Gianna Zuccotti
JAMA. 2009;301(10):1066-1069.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Seasonal, Avian, and Novel H1N1 Influenza: Prevention and Treatment Modalities
Sym et al.
The Annals of Pharmacotherapy 2009;43:2001-2011.
ABSTRACT
| FULL TEXT
Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation
Hurt et al.
J. Virol. 2009;83:10366-10373.
ABSTRACT
| FULL TEXT
Pigs might fly
Woodhead et al.
Eur Respir J 2009;33:1241-1243.
FULL TEXT
Oseltamivir-Resistant Influenza A Virus
JWatch General 2009;2009:4-4.
FULL TEXT
Influenza: Problems with Prevention and Treatment
JWatch Infect. Diseases 2009;2009:1-1.
FULL TEXT
The Evolution of Influenza Resistance and Treatment
Weinstock and Zuccotti
JAMA 2009;301:1066-1069.
FULL TEXT
|
